Human endothelial cells that make up the lining of blood vessels can be genetically altered using the CRISPR/Cas9 system, according to a study published today (May 4) in Circulation Research.

In addition to animal models, human endothelial cells grown in tissue culture provide a valuable model to understand the biology of blood vessels. Additionally, research using the cells may one day contribute to the development of methods to heal tissues by engineering them in the lab. However, because the cells are already highly specialized, they have been difficult to manipulate genetically to probe the functions of particular genes in biological processes.

In the first reported use of the CRISPR/Cas9 technique in human endothelial cells, researchers from the Yale University School of Medicine infected cultured endothelial cells with a virus containing the instructions for a Cas9 enzyme. The enzyme was designed to eliminate the gene CIITA,...

The specialization of CRISPR/Cas9 for endothelial cells offers a “provides a powerful platform for vascular research and for regenerative medicine,” the authors wrote in their paper. “The specific changes we describe might be important for using these cells in therapeutic applications such as organ repair or tissue engineering.”

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!